Skip to main content
. Author manuscript; available in PMC: 2019 Apr 2.
Published in final edited form as: Rev Recent Clin Trials. 2015;10(3):238–245. doi: 10.2174/157488711003150928130654

Table 3.

Prevalent* and incident** cancers among 104,478 Supplemental Questionnaire (SQX) respondents.

Prevalent Cases Incident Cases
Cancer Site N
All sites^ 12,012 5,094
Prostate 4,591 1,306
Breast 2,409 816
Lung 523 604
Colorectal 972 311
Bladder 606 306
NHL 489 263
Pancreas 51 149
*

Prevalent cases are defined as those diagnosed in participants after enrollment and prior to completion of the SQX (ca. 2006)

**

Incident cases include all cancer cases diagnosed between SQX completion and 13 years of follow-up from study entry or December 31st, 2009, whichever occurred earliest.

^

All confirmed cancers diagnosed in PLCO including those sites not listed individually here